Document is current
Any future updates will be listed below
-
Authors
Liu, Yongjun
Zuo, Lingyun
Li, Xiaoyun
Nie, Yao
Chen, Chuanxi
Liu, Ning
Chen, Minying
Wu, Jianfeng
Guan, Xiangdong https://orcid.org/0000-0002-5050-0359
-
Funding
Funding for this research was provided by:
Haisco Pharmaceutical Group Co., Ltd (NA)
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 7 October 2024
First Online: 26 October 2024
Declarations
:
: The phase 2 and phase 3 trials were approved by the First Affiliated Hospital of Sun Yat-sen University (phase 2 trial: 2019-037-02; phase 3 trial: 2020-057-03) and all other participating centers. The procedures used in this study adhered to the tenets of the Declaration of Helsinki and written informed consent was provided by all enrolled patients or a legal representative.
: Not applicable.
: The authors declare that they have no competing interests.
